Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2013; 19(30): 4877-4886
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4877
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4877
IBD | Montreal classification |
Crohn disease | |
Age of diagnosis | A1 below 16 yr |
A2 between 17 and 40 yr | |
A3 above 40 yr | |
Location | L1 ileal |
L2 colonic | |
L3 ileocolonic | |
L4 isolated upper disease | |
Behaviour | B1 non-stricturing, non-penetrating |
B2 stricturing | |
B3 penetrating | |
P perianal disease | |
Ulcerative colitis | |
Extent | E1 |
Ulcerative proctitis (distal to the rectosigmoid junction) | |
E2 | |
Left sided UC (distal to the splenic flexure) | |
E3 | |
Extensive UC (proximal to the splenic flexure) | |
Severity | S0 |
Clinical remission (asymptomatic) | |
S1 | |
Mild UC: Passage of four or fewer stools/d with or without blood, absence of any systemic illness, and normal inflammatory markers | |
S2 | |
Moderate UC: Passage of more than four stools per day but with minimal signs of systemic toxicity | |
S3 | |
Severe UC: Passage of at least six bloody stools daily, pulse rate of at least 90 beats/min, temperature of at least 37.5 °C, haemoglobin of less than 10.5 g/100 mL, and ESR of at least 30 mm/h |
- Citation: Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, Teresa-Galván JD, Redondo-Cerezo E. Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain. World J Gastroenterol 2013; 19(30): 4877-4886
- URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4877.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i30.4877